Pennant Capital Management LLC bought a new stake in Humana Inc. (NYSE:HUM) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 208,300 shares of the insurance provider’s stock, valued at approximately $42,939,000. Humana comprises 2.0% of Pennant Capital Management LLC’s investment portfolio, making the stock its 22nd largest position.
A number of other large investors have also recently bought and sold shares of the company. Ionic Capital Management LLC bought a new stake in shares of Humana during the first quarter valued at about $8,099,000. State Street Corp increased its stake in shares of Humana by 1.4% in the first quarter. State Street Corp now owns 6,274,811 shares of the insurance provider’s stock valued at $1,293,487,000 after buying an additional 84,716 shares in the last quarter. Weiss Multi Strategy Advisers LLC increased its stake in shares of Humana by 42.7% in the first quarter. Weiss Multi Strategy Advisers LLC now owns 10,050 shares of the insurance provider’s stock valued at $2,072,000 after buying an additional 3,008 shares in the last quarter. Oppenheimer Asset Management Inc. bought a new stake in shares of Humana during the first quarter valued at about $2,118,000. Finally, Oppenheimer & Co. Inc. increased its stake in shares of Humana by 1.1% in the first quarter. Oppenheimer & Co. Inc. now owns 18,830 shares of the insurance provider’s stock valued at $3,882,000 after buying an additional 203 shares in the last quarter. Institutional investors own 98.92% of the company’s stock.
Humana Inc. (HUM) opened at 239.37 on Wednesday. The company has a market cap of $34.54 billion, a P/E ratio of 24.40 and a beta of 0.90. The stock has a 50 day moving average of $230.72 and a 200-day moving average of $213.63. Humana Inc. has a 12 month low of $150.00 and a 12 month high of $239.41.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.55 by $0.20. Humana had a net margin of 2.71% and a return on equity of 14.38%. The firm had revenue of $13.76 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter in the prior year, the company posted $1.86 earnings per share. Equities research analysts expect that Humana Inc. will post $11.15 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 31st. Shareholders of record on Friday, June 30th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, June 28th. This represents a $1.60 annualized dividend and a yield of 0.67%. Humana’s payout ratio is 16.24%.
ILLEGAL ACTIVITY NOTICE: “Pennant Capital Management LLC Takes Position in Humana Inc. (HUM)” was originally posted by sleekmoney and is the property of of sleekmoney. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://sleekmoney.com/pennant-capital-management-llc-takes-position-in-humana-inc-hum/1946201.html.
Several brokerages have recently issued reports on HUM. Citigroup Inc. began coverage on shares of Humana in a research report on Wednesday. They set a “buy” rating for the company. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, June 21st. Royal Bank Of Canada reissued a “hold” rating and set a $214.00 price objective on shares of Humana in a research report on Monday, June 5th. BidaskClub downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Finally, Cantor Fitzgerald reissued a “neutral” rating on shares of Humana in a research report on Friday, June 23rd. Eight investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $223.16.
In other news, CEO Bruce D. Broussard sold 118,231 shares of the company’s stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $225.82, for a total value of $26,698,924.42. Following the completion of the sale, the chief executive officer now owns 171,170 shares in the company, valued at approximately $38,653,609.40. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Timothy S. Huval sold 13,939 shares of the company’s stock in a transaction on Thursday, May 4th. The stock was sold at an average price of $225.86, for a total transaction of $3,148,262.54. Following the completion of the sale, the vice president now owns 23,639 shares of the company’s stock, valued at approximately $5,339,104.54. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 138,270 shares of company stock worth $31,253,863. Corporate insiders own 0.80% of the company’s stock.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/pennant-capital-management-llc-takes-position-in-humana-inc-hum/1946201.html
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.